跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REMINYL 24 MG CAPSULAS DURAS DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
REMINYL 24 MG CAPSULAS DURAS DE LIBERACION PROLONGADA
Approved
STANDARD
REMINYL 24 MG CAPSULAS DURAS DE LIBERACION PROLONGADA
Janssen Cilag Pharmaceutical S.A.C.I.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 25, 2021
Approval ID
f63f1a021916955d
Company
Janssen Cilag Pharmaceutical S.A.C.I.
Type
Standard
Approval Details
Approval Id
f63f1a021916955d
Drug Cima Aemps Name
REMINYL 24 MG CAPSULAS DURAS DE LIBERACION PROLONGADA
Register Number
29843-08-05-2008
Holder Company Name
Janssen Cilag Pharmaceutical S.A.C.I.
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2021-08-25
Dosage Form
CÁPSULA DURA DE LIBERACIÓN PROLONGADA
Dose
24 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Janssen Cilag Pharmaceutical S.A.C.I.
Active Ingredients
GALANTAMINA HIDROBROMURO
24 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 25, 2021
Approval ID
f63f1a021916955d
Type
Standard
Back to CIMA-AEMPS Approvals
